BRTX
Price
$1.60
Change
-$0.03 (-1.84%)
Updated
Sep 5 closing price
Capitalization
12.76M
73 days until earnings call
CERO
Price
$5.92
Change
-$1.01 (-14.57%)
Updated
Sep 5 closing price
Capitalization
7.14M
Interact to see
Advertisement

BRTX vs CERO

Header iconBRTX vs CERO Comparison
Open Charts BRTX vs CEROBanner chart's image
BioRestorative Therapies
Price$1.60
Change-$0.03 (-1.84%)
Volume$36.32K
Capitalization12.76M
CERO Therapeutics Holdings
Price$5.92
Change-$1.01 (-14.57%)
Volume$4.7M
Capitalization7.14M
BRTX vs CERO Comparison Chart in %
Loading...
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRTX vs. CERO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRTX is a Hold and CERO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BRTX: $1.60 vs. CERO: $5.92)
Brand notoriety: BRTX and CERO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRTX: 39% vs. CERO: 2919%
Market capitalization -- BRTX: $12.76M vs. CERO: $7.14M
BRTX [@Biotechnology] is valued at $12.76M. CERO’s [@Biotechnology] market capitalization is $7.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRTX’s FA Score shows that 1 FA rating(s) are green whileCERO’s FA Score has 1 green FA rating(s).

  • BRTX’s FA Score: 1 green, 4 red.
  • CERO’s FA Score: 1 green, 4 red.
According to our system of comparison, BRTX is a better buy in the long-term than CERO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRTX’s TA Score shows that 5 TA indicator(s) are bullish while CERO’s TA Score has 5 bullish TA indicator(s).

  • BRTX’s TA Score: 5 bullish, 5 bearish.
  • CERO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CERO is a better buy in the short-term than BRTX.

Price Growth

BRTX (@Biotechnology) experienced а -13.04% price change this week, while CERO (@Biotechnology) price change was -21.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

BRTX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRTX($12.8M) has a higher market cap than CERO($7.14M). BRTX YTD gains are higher at: 11.888 vs. CERO (-95.067). BRTX has more cash in the bank: 7.38M vs. CERO (5.2M). BRTX has less debt than CERO: BRTX (42.4K) vs CERO (1.37M).
BRTXCEROBRTX / CERO
Capitalization12.8M7.14M179%
EBITDA-12.89MN/A-
Gain YTD11.888-95.067-13%
P/E RatioN/AN/A-
Revenue605KN/A-
Total Cash7.38M5.2M142%
Total Debt42.4K1.37M3%
FUNDAMENTALS RATINGS
BRTX: Fundamental Ratings
BRTX
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BRTXCERO
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
43%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
42%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
26%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 9 days ago
86%
Bullish Trend about 1 month ago
57%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
31%
View a ticker or compare two or three
Interact to see
Advertisement
BRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTUS17.040.28
+1.67%
Metallus
PCH42.870.67
+1.59%
PotlatchDeltic Corp
ZM83.680.89
+1.08%
Zoom Communications Inc
HPAI3.970.02
+0.48%
Helport AI Limited
FLYE0.65-0.01
-1.53%
Fly-E Group Inc

BRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRTX has been loosely correlated with SBMFF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BRTX jumps, then SBMFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRTX
1D Price
Change %
BRTX100%
-1.84%
SBMFF - BRTX
35%
Loosely correlated
N/A
RNA - BRTX
33%
Poorly correlated
+3.90%
CERO - BRTX
29%
Poorly correlated
-14.57%
VRNA - BRTX
28%
Poorly correlated
+0.07%
INRLF - BRTX
27%
Poorly correlated
N/A
More

CERO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERO has been loosely correlated with CBIO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CERO jumps, then CBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERO
1D Price
Change %
CERO100%
-14.57%
CBIO - CERO
47%
Loosely correlated
+4.02%
UNCY - CERO
37%
Loosely correlated
+0.93%
UTHR - CERO
33%
Loosely correlated
+5.27%
ACXP - CERO
32%
Poorly correlated
+5.70%
IBIO - CERO
30%
Poorly correlated
+2.92%
More